EPREX (Epoetin Alfa) Versus ARANESP (Darbepoetin Alfa): Looking at Outcome of Anemia Treatment and Comparing Cost-effectiveness (EVALUATE).
Phase of Trial: Phase IV
Latest Information Update: 20 Jun 2014
At a glance
- Drugs Epoetin alfa (Primary) ; Darbepoetin alfa
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms EVALUATE
- Sponsors Janssen-Cilag
- 04 Apr 2012 Actual patient number changed from 494 to 492 added as reported by ClinicalTrials.gov.
- 04 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Dec 2010 Planned End Date changed from 1 Dec 2010 to 1 Feb 2011 as reported by ClinicalTrials.gov.